CombinatoRx and Fovea in Alliance to Treat Ophthalmic Disease
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 69 (Table of Contents)
Published: 6 Mar-2006
DOI: 10.3833/pdr.v2006.i69.542 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
CombinatoRx and Fovea Pharmaceuticals entered into a collaboration agreement to develop and potentially commercialize combination drugs to treat ophthalmic diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS